Entity

Time filter

Source Type


Annala M.,Tampere University of Technology | Kivinummi K.,Institute of Biosciences and Medical Technology Tampere Finland | Leinonen K.,Institute of Biosciences and Medical Technology Tampere Finland | Tuominen J.,Institute of Biosciences and Medical Technology Tampere Finland | And 3 more authors.
EMBO Molecular Medicine | Year: 2014

Evidence is presented for a case of androgen receptor-negative prostate cancer driven by a DOT1L-HES6 fusion gene which directly induces overexpression and pathological activation of HES6. © 2014 The Authors. Source

Discover hidden collaborations